Top Markets
#1 Black Phoenix Black Phoenix +21,499.43%
#2 Nesa Nesa +689.85%
#3 Kinesis Silver Kinesis Silver +55.32%
#4 Ontology Gas Ontology Gas +50.74%
#5 QuantixAI QuantixAI +23.07%
#6 EXOD EXOD +22.78%
#7 BNB Attestation Service BNB Attestation Service +21.67%
#8 SAFEcoin SAFEcoin +20.65%
#9 Biconomy Biconomy +19.25%
#10 Magma Finance Magma Finance +18.34%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rank in Stocks #19182
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Share Price
$4.62
Last synced: 2023-03-23
Market Cap
$171.76M
Change (1 day)
-37.16%
Change (1 year)
0.00%
Country
KR
Trade Cellivery Therapeutics, Inc. (268600)

Category

Healthcare
Number of shares outstanding for Cellivery Therapeutics, Inc. (268600)
Number of shares outstanding as of August 2026: 0
According to Cellivery Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cellivery Therapeutics, Inc. (268600) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH